MEDICAL MICROBIOLOGY AND IMMUNOLOGY 期刊简介
Medical Microbiology and Immunology (MMIM) publishes key findings on all aspects of the interrelationship between infectious agents and the immune system of their hosts. The journal´s main focus is original research work on intrinsic, innate or adaptive immune responses to viral, bacterial, fungal and parasitic (protozoan and helminthic) infections and on the virulence of the respective infectious pathogens.
MMIM covers basic, translational as well as clinical research in infectious diseases and infectious disease immunology. Basic research using cell cultures, organoid, and animal models are welcome, provided that the models have a clinical correlate and address a relevant medical question.
The journal also considers manuscripts on the epidemiology of infectious diseases, including the emergence and epidemic spreading of pathogens and the development of resistance to anti-infective therapies, and on novel vaccines and other innovative measurements of prevention.
The following categories of manuscripts will not be considered for publication in MMIM:
submissions of preliminary work, of merely descriptive data sets without investigation of mechanisms or of limited global interest,
manuscripts on existing or novel anti-infective compounds, which focus on pharmaceutical or pharmacological aspects of the drugs,
manuscripts on existing or modified vaccines, unless they report on experimental or clinical efficacy studies or provide new immunological information on their mode of action,
manuscripts on the diagnostics of infectious diseases, unless they offer a novel concept to solve a pending diagnostic problem,
case reports or case series, unless they are embedded in a study that focuses on the anti-infectious immune response and/or on the virulence of a pathogen.
医学微生物学和免疫学 (MMIM) 发布了有关感染因子与其宿主免疫系统之间相互关系的各个方面的关键发现。该杂志的主要重点是对病毒,细菌,真菌和寄生虫 (原生动物和蠕虫) 感染的内在,先天或适应性免疫反应以及各自传染性病原体的毒力的原始研究工作。
MMIM涵盖基本,传染病和传染病免疫学的转化和临床研究。欢迎使用细胞培养物,类器官和动物模型进行基础研究,只要这些模型具有临床相关性并解决相关的医学问题。
该杂志还考虑了有关传染病流行病学的手稿,包括病原体的出现和流行以及对抗感染疗法的耐药性的发展,以及新型疫苗和其他创新的预防措施。
以下类别的手稿将不考虑在MMIM中出版:
提交的初步工作,仅是描述性数据集,而没有机制的调查或有限的全球兴趣,
关于现有或新型抗感染化合物的手稿,其重点是药物或药理学方面的药物,
关于现有或改良疫苗的手稿,除非他们报告实验或临床疗效研究或提供有关其作用方式的新的免疫学信息,
关于传染病诊断的手稿,除非他们提供了一个新颖的概念来解决悬而未决的诊断问题,
病例报告或病例系列,除非将它们嵌入到专注于抗感染免疫反应和/或病原体毒力的研究中。
期刊ISSN
|
0300-8584 |
影响指数
|
3.368 |
最新CiteScore值
|
4.60 查看CiteScore评价数据 |
最新自引率
|
0.60% |
官方指定润色网址
|
https://www.deeredit.com/?type=ss1 |
投稿语言要求
|
Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted. 建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率 |
期刊官方网址
hot |
https://www.peipusci.com/?type=9 |
杂志社征稿网址
hot |
https://www.peipusci.com/?type=10 |
通讯地址
|
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013 |
偏重的研究方向(学科)
|
医学-免疫学 |
出版周期
|
Quarterly |
出版年份
|
1886 |
出版国家/地区
|
GERMANY |
是否OA
|
No |
SCI期刊coverage
|
Science Citation Index Expanded(科学引文索引扩展) |
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
最新中科院JCR分区
|
大类(学科)
小类(学科)
综述期刊
医学
IMMUNOLOGY(免疫学)4区
MICROBIOLOGY(微生物学)3区
否
|
|||||
最新的影响因子
|
3.368 | |||||
最新公布的期刊年发文量 |
|
|||||
总被引频次 | 54 | |||||
影响因子趋势图 |
近年的影响因子趋势图(整体平稳趋势)
|
2022年预警名单预测最新
最新CiteScore值
|
4.60
|
||||||||||||||||||
年文章数 | 59 | ||||||||||||||||||
SJR
|
0.954 | ||||||||||||||||||
SNIP
|
0.916 | ||||||||||||||||||
CiteScore排名
|
|
||||||||||||||||||
CiteScore趋势图 |
CiteScore趋势图
|
本刊同领域相关期刊
|
|
期刊名称 | IF值 |
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY | 2.026 |
AIDS | 4.135 |
APMIS | 3.173 |
VACCINE | 3.605 |
BIODRUGS | 5.749 |
IMMUNITY | 31.428 |
LYMPHOLOGY | 1.273 |
Lancet HIV | 12.639 |
AIDS REVIEWS | 2.475 |
本刊同分区等级的相关期刊
|
|
期刊名称 | IF值 |
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY | 2.026 |
VACCINE | 3.605 |
AIDS REVIEWS | 2.475 |
AUTOIMMUNITY | 2.787 |
TUBERCULOSIS | 3.1 |
IMMUNOBIOLOGY | 3.113 |
Immunotherapy | 4.154 |
BMC IMMUNOLOGY | 3.579 |
IMMUNOLOGY LETTERS | 3.648 |
分享者 | 点评内容 |